skip to Main Content

Tilray® Receives Approval from U.S. Government to Import a Medical Cannabis Study Drug for a Clinical Trial at the University of California San Diego Center for Medicinal Cannabis Research

PRESS RELEASE U.S. Drug Enforcement Administration approves import of a pharmaceutical-grade medical cannabis product produced by Tilray into the United States for a clinical trial focused on Essential Tremor NANAIMO, B.C. – Tilray Inc. (NASDAQ:TLRY) today announced that the U.S.…

Read More
Back To Top
×Close search